Mach7 TechnologiesTDMMF -10.12%32 PS Ratio is 4.54 as of Jul. 04, 2026, which is 42% below its 10-year median of 7.83. GuruFocus rates TDMMF with a GF Score™ of 32/100 and a GF Value™ of $0.61 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 659 Healthcare Providers & Services companies, Mach7 Technologies ranks worse than 77.54% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Mach7 Technologies's share price is $0.2132.
Mach7 Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $0.05. Hence, Mach7 Technologies's PS Ratio for today is 4.54.
The historical rank and industry rank for Mach7 Technologies's PS Ratio or its related term are showing as below:
TDMMF'
s PS Ratio Range Over the Past 10 Years
Min: 1.59 Med: 7.83 Max: 15.3
Current: 4.15
During the past 13 years, Mach7 Technologies's highest PS Ratio was 15.30. The lowest was 1.59. And the median was 7.83.
TDMMF's PS Ratio is ranked worse than 77.54% of 659
companies
in the Healthcare Providers & Services industry
Industry Median: 1.52
vs TDMMF: 4.15
Mach7 Technologies Ltd revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue per Share Growth Rate of Mach7 Technologies was -21.10% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 3.30% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -4.30% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 15.50% per year.
During the past 13 years, Mach7 Technologies's highest 3-Year average Revenue per Share Growth Rate was 163.80% per year. The lowest was -93.10% per year. And the median was 5.70% per year.
Back to Basics: PS Ratio
Mach7 Technologies (OTCPK:TDMMF) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Mach7 Technologies PS Ratio Related Terms
Mach7 Technologies PS Ratio Historical Data
* Premium members only.
The historical data trend for Mach7 Technologies's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Mach7 Technologies's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mach7 Technologies PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Mach7 Technologies's PS Ratio distribution charts can be found below:
* The bar in red indicates where Mach7 Technologies's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Mach7 Technologies's Share Price of today is $0.2132.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Mach7 Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $0.05.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Mach7 Technologies (TDMMF) has a PS Ratio of 4.54 as of Jul. 04, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Mach7 Technologies and its competitors. This is 42% below median its historical median of 7.83. Over the past decade, Mach7 Technologies' PS Ratio has ranged from 1.59 to 15.30. According to the industry distribution chart, Mach7 Technologies ranks #511 out of 659 companies in the Healthcare Providers & Services industry, placing it in the top 77.5%.
Is Mach7 Technologies' PS Ratio too high?
Mach7 Technologies' current PS Ratio of 4.54 is 42% below median its 10-year median of 7.83. Over the past 10 years, this metric has ranged from a low of 1.59 to a high of 15.30. The Healthcare Providers & Services industry median PS Ratio is 1.52. Mach7 Technologies' value of 4.54 is 198.7% above this industry median. Based on the distribution chart, Mach7 Technologies ranks #511 out of 659 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Mach7 Technologies has a GF Score™ of 32/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Mach7 Technologies' PS Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Mach7 Technologies ranks #511 out of 659 companies for PS Ratio. This places Mach7 Technologies in the lower half of its industry. The industry median PS Ratio is 1.52. Mach7 Technologies' value of 4.54 is 198.7% above this benchmark. Historically, Mach7 Technologies' own PS Ratio has ranged from 1.59 to 15.30 over the past decade. While the company's 10-year median is 7.83 vs. the industry median of 1.52, Mach7 Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.52, based on 659 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mach7 Technologies's current PS Ratio of 4.54 is 198.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Mach7 Technologies and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mach7 Technologies's current PS Ratio is 4.54, which is 42% below median its own 10-year median of 7.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mach7 Technologies stock overvalued right now?
Based on GuruFocus' analysis, Mach7 Technologies (TDMMF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.61, compared to a current price of $0.21 — trading 65% below its estimated fair value. The current PS Ratio is 4.54, which is 42% below median its 10-year median of 7.83 and 198.7% above the Healthcare Providers & Services industry median of 1.52. Mach7 Technologies' overall GF Score™ is 32/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Mach7 Technologies (TDMMF), the current PS Ratio is 4.54 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mach7 Technologies (TDMMF) Overvalued in 2026?
Based on GuruFocus' analysis, Mach7 Technologies stock appears to be undervalued.
The current stock price of $0.21 is trading 65% below its estimated GF Value™ of $0.61.
GuruFocus considers Mach7 Technologies to be Possible Value Trap.
Key valuation signals for TDMMF:
PS Ratio: 4.54 (42% below median its 10-year median of 7.83)
GF Value™: $0.61 vs. price of $0.21 (65% below fair value)
Industry Position: 198.7% above the Healthcare Providers & Services median (#511 of 659)
No single metric tells the full story. See the TDMMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mach7 Technologies Ltd is a healthcare software company focused on enterprise imaging infrastructure. The company's vendor neutral platform enables health systems to manage, access, and exchange medical imaging data across departments, sites, and vendors. It serves across North America, Asia-Pacific, and the Middle East, with deployments ranging from academic medical centres to multi-site health networks. A substantial part of revenue is derived in the form of Subscription revenue. Geographically, it derives a majority of its revenue from North America.
32GF Score
Get the complete analysis for TDMMF
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TDMMF has been successfully added to your 
